CLINICAL CHALLENGES AND ADVANCES IN THE DIAGNOSIS OF LIGHT CHAIN AMYLOIDOSIS
ARACÊ · 16.07.2026 · 8 (7) · e13805
DOI: 10.56238/arev8n7-070 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARACÊ, online erschienen am 16.07.2026. Verfasst von Mariane Barbosa Carvalho und 11 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Light chain amyloidosis (AL) is a serious plasmacytic dyscrasia characterized by extracellular deposition of amyloid fibrils that compromise vital organs and have high mortality rates. This study, structured as a narrative literature review, analyzes the main diagnostic challenges and advances in precision medicine for this pathology. The literature demonstrates that the insidious nature of the disease and clinical nonspecificity frequently cause significant diagnostic delays, making early identification of clinical red flags crucial. The propedeutic transition from invasive biopsies to safer techniques, such as mass spectrometry, has been fundamental. In the therapeutic context, the landscape has changed drastically with the incorporation of monoclonal antibodies such as daratumumab in first-line regimens and the targeted use of BCL-2 inhibitors, such as venetoclax, for patients with the t(11;14) translocation. The article concludes that the integration of sensitive cardiac and hematologic biomarkers, combined with precision therapy strategies, is essential to transform the grim prognosis of AL amyloidosis into a manageable chronic condition. Multidisciplinary care and prompt diagnosis are imperative for reversing irreversible organ damage and improving patients' quality of life.
Zitieren
APA
Carvalho, M. B., Xavier, A. G. B., Oliveira, M. R. D., Magalhães, T. L., Gonçalves, L. P., Ferreira, A. B. D. S., Silva, B. C. P. D., Pereira, L. S. O., Dantas, A. L. N., Pimenta, B. M., Monte, P. J. F. R., & Souza, E. F. B. D. (2026). CLINICAL CHALLENGES AND ADVANCES IN THE DIAGNOSIS OF LIGHT CHAIN AMYLOIDOSIS. ARACÊ, 8(7), e13805. https://doi.org/10.56238/arev8n7-070
Vancouver
Carvalho MB, Xavier AGB, Oliveira MRD, Magalhães TL, Gonçalves LP, Ferreira ABDS, et al. CLINICAL CHALLENGES AND ADVANCES IN THE DIAGNOSIS OF LIGHT CHAIN AMYLOIDOSIS. ARACÊ. 2026;8(7):e13805. doi:10.56238/arev8n7-070
BibTeX
@article{Carvalho2026,
author = {Carvalho, Mariane Barbosa and Xavier, Arthur Godoy Barbosa and Oliveira, Matheus Rodrigues de and Magalhães, Thayná Lima and Gonçalves, Laylla Patricio and Ferreira, Amandha Bárbara dos Santos and Silva, Beatriz Correa Pinto da and Pereira, Letícia Stella Oliveira and Dantas, André Lucas Nogueira and Pimenta, Bárbara Machado and Monte, Paulo José Fernandes Rosa and Souza, Eduardo Ferreira Barreto de},
title = {CLINICAL CHALLENGES AND ADVANCES IN THE DIAGNOSIS OF LIGHT CHAIN AMYLOIDOSIS},
journal = {ARACÊ},
year = {2026},
volume = {8},
number = {7},
pages = {e13805},
doi = {10.56238/arev8n7-070}
}
EUVIMED